TORONTO-Standards proposed by the United States Pharmacopeia (USP) for the compounding of sterile medication could be applied to vial mixing in the office. This would represent a radical change that won’t make many otolarygnologists happy, according to panelists at the recent annual meeting of the American Academy of Otolaryngic Allergy (AAOA).
Explore this issue:November 2006
Although the changes would represent a significant effect on practice, not many otolaryngologists seem to be aware of them, yet they could actually happen, panelists warned.
One of the significant problems with the proposed USP standards is that they state that mixing must be performed in a dedicated clean room with a laminar flow hood. The specially built rooms would cost an estimated minimum of $21,000-a figure that some participants at the AAOA speculated would be significantly higher in reality. The standards would apply to physicians of all specialities who perform sterile medication compounding.